URL has been copied successfully!
Skip to content
JBizNews
JBizNews
Primary Navigation Menu
Menu
  • Home
  • Breaking News
  • Top News
  • Markets
  • Crypto
  • Health
  • Real Estate
  • Events
  • Subscribe
  • About JBizNews

Health

  • April 20, 2026

    3 questions every payer should ask about medical AI


  • April 20, 2026

    Times up: Hospitals and the 340B markup program need reforms


  • April 20, 2026

    3 ways AI is humanizing patient care


  • April 20, 2026

    STAT+: A controversy over research monkeys highlights ambiguity over health standards


  • April 20, 2026

    Opinion: Politicians are using low teen birth rates to further restrict access to birth control, abortion


  • April 20, 2026

    STAT+: PBMs warn Trump’s proposal to disclose drug prices is illegal


  • April 20, 2026

    Opinion: Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures


  • April 20, 2026

    Even for trans adults, care is hard to find: ‘I could not do it on my own’


  • April 19, 2026

    STAT+: AACR 2026: More strong data for Revolution Medicines’ KRAS drug


  • April 19, 2026

    STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades


  • April 18, 2026

    How Trump is pushing psychedelics reform through the health agencies


  • April 18, 2026

    Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role


  • April 18, 2026

    Opinion: The podcast bringing together MAHA and public health for hard conversations


  • April 17, 2026

    STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment


  • April 17, 2026

    Stakeholders urge Labor Department to finalize PBM transparency rule


  • April 17, 2026

    CMS proposes repeal of add-on payment path for breakthrough devices


  • April 17, 2026

    STAT+: FDA eyes expanding testosterone therapy for libido


  • April 17, 2026

    STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more


  • April 17, 2026

    The deadly consequences of ICE detention


  • April 17, 2026

    Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director


  • April 17, 2026

    Opinion: Health care is not ready for the new era of AI-enabled cyberattacks


  • April 17, 2026

    Opinion: Don’t believe headlines saying that vaccine skepticism is widespread


  • April 17, 2026

    STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows


  • April 16, 2026

    Xanax XR recalled after discovery that tablets may fail to release medication properly


  • April 16, 2026

    STAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions


  • April 16, 2026

    STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearings


  • April 16, 2026

    Trump Taps Former Public Health Leader Erica Schwartz to Lead CDC


  • April 16, 2026

    A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment


  • April 16, 2026

    Trump taps former public health leader Erica Schwartz to run CDC


  • April 16, 2026

    Abridge partners with medical journals to expand AI clinical decision support


  • April 16, 2026

    ACA exchanges will continue to shrink as fewer enrollees pay premiums, analysis suggests


  • April 16, 2026

    More employers considering medical, pharmacy vendor switch amid rising healthcare costs, survey finds


  • April 16, 2026

    FDA moves toward easing restrictions on certain peptides


  • April 16, 2026

    Walmart expands digital health platform’s weight loss offerings, including GLP-1 prescribing


  • April 16, 2026

    STAT+: Cochrane review reignites Alzheimer’s amyloid wars


  • April 16, 2026

    STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target


  • April 16, 2026

    STAT+: RFK Jr. begins his testimony marathon


  • April 16, 2026

    STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more


  • April 16, 2026

    STAT+: Medicare may nix breakthrough device payment pathway


  • April 16, 2026

    The mental health parity gap is gaping


Previous Page
1 … 31 32 33 34 35 … 40
Next Page
2026-03-30

JBIZNEWS LLC © 2026